CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
PathChooser focuses on improving drug delivery across biological barriers using nanomedicine. The project emphasizes understanding cellular processes and designing effective carriers to enhance treatment for challenging diseases, including those affecting the brain.
Nanomedicine offers capability to significantly change the course of treatment for life-threatening diseases.
Many of the most significant current therapeutic targets, to be viable in practice, require the efficient crossing of at least one biological barrier.
However, the efficient and controlled crossing of the undamaged barrier is difficult.
The range of small molecules that can successfully do so (via diffusive or other non-specific processes) is limited in size and physiochemical properties…
UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Denmark, Odense M
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, London
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Cyprus, Lefkosia
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
